
Payden Equity Income Fund Adviser Cl
PYVAX
Updated: 23/09/2026, 12:27:05
The Payden Equity Income Fund endeavors to deliver both long-term capital appreciation and a consistent level of current income to its investors. Its investment strategy primarily centers on well-established, large-capitalization value stocks, identified by their substantial market value and tendency to offer above-average dividend yields. The fund also diversifies into other equity-related instruments that produce income, such as preferred shares, real estate investment trusts (REITs), and master limited partnerships (MLPs). While the majority of its holdings are in U.S. securities, the fund retains the option to allocate up to 30% of its total assets to international equities, including those from developing nations.
No summaries found.
- Share price
- $18.96
- Market cap
- $1.35B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 01/12/2011
- Beta
- 0.782
- Last dividend
- $0.00
- Day range
- $18.96 – $19.07
- 52-week range
- $16.61 – $19.36
- 1-day performance
- -0.58%
- 1-year performance
- 14.15%
- Current drawdown (1Y)
- -2.07%
- CIK
- 0000885709
- CUSIP
- 704329259
- ISIN
- US7043292595
- Created
- 07/12/2025, 13:52:07
- Last update
- 23/09/2026, 12:27:05
Track Payden Equity Income Fund Adviser Cl with an AI analyst
See which prediction-market events move PYVAX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.